Literature DB >> 30485882

Acute Liver Failure.

Priyanka Rajaram1, Ram Subramanian1.   

Abstract

Acute liver failure (ALF) is a condition that can rapidly progress to multiorgan failure. This article focuses on the diagnosis and management of ALF. We provide a detailed review of the common etiologies of ALF, including acetaminophen overdose, viral hepatitis, drug-induced liver injury, Wilson's disease, and autoimmune hepatitis. The article then addresses how to recognize ALF and reviews the role of common laboratory and imaging tests in establishing this diagnosis. The remainder of the article details the management of hepatic and extrahepatic organ dysfunctions in ALF. The article concludes with a discussion regarding the prognostication of patients with ALF and the criteria for considering liver transplantation. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30485882     DOI： 10.1055/s-0038-1673372

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN： 1069-3424            Impact factor:   3.119


  10 in total

1.  Improvement Effect of PERMA Model-Based Nursing Intervention plus Music Therapy on Patients with Acute Liver Failure Undergoing Plasma Exchange Therapy.

Authors:  Jinhua Wang; Wei Li
Journal:  Emerg Med Int       Date:  2022-06-29       Impact factor: 1.621

2.  Network Pharmacology-Based Prediction and Pharmacological Validation of Effects of Astragali Radix on Acetaminophen-Induced Liver Injury.

Authors:  Yuan Peng; Gerui Zhu; Yuanyuan Ma; Kai Huang; Gaofeng Chen; Chenghai Liu; Yanyan Tao
Journal:  Front Med (Lausanne)       Date:  2022-07-04

Review 3.  Hepatitis D virus and liver transplantation: Indications and outcomes.

Authors:  Haris Muhammad; Aniqa Tehreem; Muhammad Baraa Hammami; Peng-Sheng Ting; Ramzan Idilman; Ahmet Gurakar
Journal:  World J Hepatol       Date:  2021-03-27

4.  25-Hydroxycholesterol 3-Sulfate Recovers Acetaminophen Induced Acute Liver Injury via Stabilizing Mitochondria in Mouse Models.

Authors:  Yaping Wang; William M Pandak; Edward J Lesnefsky; Phillip B Hylemon; Shunlin Ren
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

5.  The Qingchangligan Formula Alleviates Acute Liver Failure by Regulating Galactose Metabolism and Gut Microbiota.

Authors:  Ruiying Yin; Shuhui Liu; Xuejiao Jiang; Xiangying Zhang; Feili Wei; Jianhua Hu
Journal:  Front Cell Infect Microbiol       Date:  2022-01-19       Impact factor: 5.293

6.  Recombinant Human HPS Protects Mice and Nonhuman Primates from Acute Liver Injury.

Authors:  Yang Yang; Huali Zhai; Yue Wan; Xiaofang Wang; Hui Chen; Lihou Dong; Taoyun Liu; Guifang Dou; Chutse Wu; Miao Yu
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

7.  A modified kidney-sparing portal vein arterialization model of heterotopic auxiliary liver transplantation increases liver IL-6, TNF-α, and HGF levels and enhances liver regeneration: an animal model.

Authors:  Jun Li; Jianjun Ren; JunJing Zhang; Xingkai Meng
Journal:  BMC Surg       Date:  2022-07-21       Impact factor: 2.030

8.  Identification of key genes and infiltrating immune cells among acetaminophen-induced acute liver failure and HBV-associated acute liver failure.

Authors:  Min Shi; Zhuyi Zhou; Zhongxia Zhou; Lijuan Shen; Jianbo Shen; Guoxiong Zhou; Renfei Zhu
Journal:  Ann Transl Med       Date:  2022-07

Review 9.  Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients.

Authors:  Aritz Perez Ruiz de Garibay; Andreas Kortgen; Julia Leonhardt; Alexander Zipprich; Michael Bauer
Journal:  Crit Care       Date:  2022-09-26       Impact factor: 19.334

Review 10.  Perspective of placenta derived mesenchymal stem cells in acute liver failure.

Authors:  Mahshid Saleh; Mohammad Taher; Amir Ali Sohrabpour; Amir Abbas Vaezi; Mohsen Nasiri Toosi; Maria Kavianpour; Zeinab Ghazvinian; Shahrokh Abdolahi; Javad Verdi
Journal:  Cell Biosci       Date:  2020-05-24       Impact factor: 7.133
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.